Wireless In Situ Sensors in Stents for the Treatment and Monitoring of Chronic Obstructive Lung Disease (COPD)
- 技术优势
- Easy to upgrade or replace current stentsSafe and convenient Does not require specialized equipmentFacile and comprehensive management of patients
- 技术应用
- Wireless biosensorMonitor patients with emphysema and all forms of COPDOrthopedic and dental implantsWearable fabric (smart patch, band-aid, or cast) for early detection of infection or inflammation
- 详细技术说明
- Researchers led by Professor William Kaiser have invented a novel wireless, passive, and biocompatible sensor that can sense flow in bronchoscopically implanted stents in situ and in the absences of specialized equipment. This invention can be used as a straightforward electromechanical upgrade to current stent fabrication methods and can be used in place of current stents. This technology offers a safe and convenient method for effectively guiding COPD rehabilitation and treatment that has not been previously available and could potentially be used for other biosensing applications, such as orthopedic and dental implants as well as wearable fabrics (i.e. smart patches).
- *Abstract
-
UCLA researchers in the Department of Electrical Engineering have developed a novel wireless sensor for external and internal biosensing applications.
- *IP Issue Date
- Nov 9, 2017
- *Principal Investigation
-
Name: Denise Aberle
Department:
Name: Maxim Batalin
Department:
Name: William Kaiser
Department:
Name: Alireza Mehrnia
Department:
Name: Ani Nahapetian
Department:
Name: Majid Sarrafzadeh
Department:
Name: James Sayre
Department:
- 申请号码
- 20170319096
- 其他
-
State Of Development
Wireless sensor system development confirms feasibility
Background
Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating disease affecting between 10-24 million adults in the U.S. alone, and is expected to become the third most common cause of death worldwide within the next decade. Routine visits are necessary for patients after undergoing lung volume reduction surgery to monitor for changes in pulmonary function and complications, but real time changes in lung function can be missed during these visits. The addition of sensor technology to stents has the potential to transform the treatment for emphysema, as it will decrease the risk of delay in determining complications and provide on-demand feedback without a visit to the clinic.
Related Materials
L. K. Au and W. J. Kaiser. Biosensing Platforms for Wireless Health. Proc. of SPIE. 2009.
L. K. Au, M. A. Batalin, T. Stathopoulos, A. A. T. Bui, and W. J. Kaiser. Episodic Sampling: Towards Energy-efficient Patient Monitoring with Wearable Sensors. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2009.Additional Technologies by these Inventors
Tech ID/UC Case
28698/2009-406-0
Related Cases
2009-406-0
- 国家/地区
- 美国
